ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-OR116

CKDu in Mexico: The Case of Poncitlán, Jalisco

Session Information

Category: Chronic Kidney Disease (Non-Dialysis)

  • 301 CKD: Risk Factors for Incidence and Progression

Authors

  • Garcia-Garcia, Guillermo, Hospital Civil De Guadalajara, University of Guadalajara, Guadalajara, Mexico
  • Morraz Mej?a, Evelyn Fabiola, Hospital Civil De Guadalajara, University of Guadalajara, Guadalajara, Mexico
  • Montalban, José Manuel, Hospital Civil De Guadalajara, University of Guadalajara, Guadalajara, Mexico
  • Chavez, Jonathan, Hospital Civil De Guadalajara, University of Guadalajara, Guadalajara, Mexico
  • Vazquez martinez, Luz E, Hospital Civil De Guadalajara, University of Guadalajara, Guadalajara, Mexico
  • Pacheco, Eduardo Nungaray, Hospital Civil De Guadalajara, University of Guadalajara, Guadalajara, Mexico
  • Renoirte, Karina, Hospital Civil De Guadalajara, University of Guadalajara, Guadalajara, Mexico
Background

An elevated prevalence of CKD of unspecified cause (CKDu) has been documented in various developing countries. It has been reported by the media a high prevalence of CKDu in towns located by Chapala Lake, Mexico, particularly in the communities of San Pedro Itzican, Agua Caliente, and Mezcala, in Poncitlan, Mexico. Environmental factors have been blamed as the probable cause of the pandemia.

Methods

Since 2006, we pioneered screening people at risk for the presence of CKD using mobile units that travel to rural and urban communities of Jalisco. Trained personnel collected demographic and clinical data, and obtained blood and urine for serum chemistry and dipstick urinalysis. Those individuals who were aware they had kidney disease were not assessed; all others were eligible to participate. GFR was estimated with the MDRD formula. CKD was defined as an eGFR < 60 ml/min/1.73m2.

Results

Between 2007-2016, 50,909 adults were screened with the mobile units. Findings in individuals residing in Poncitlan were compared with those living in other Jalisco municipalities (Table)

Conclusion

CKD and proteinuria were highly prevalent among individuals living in communities of Poncitlan, Mexico. CKD prevalence was two-fold higher among the adult population in comparison with other Jalisco municipalities. Prevalence of proteinuria was three-fold higher than in other communities of Jalisco. Undergoing studies will provide information on the causes of this epidemic

Results
 All
n=50,909
Poncitlan
n=283
Other municipalities
n= 50,626
p
Age, y52.33±14.8250.92±17.1652.32±14.800.173
Male, %32.021.932.10.000
Known DM, %22.515.922.50.03
Known HTN, %32.726.932.70.113
SBP ≥ 140, %39.547.939.40.005
DBP ≥ 90 , %20.420.720.40.888
% with IMC ≥ 3035.426.835.40.001
% with eGFR < 60 ml/min/1.73 m210.620.110.40.002
% with dipstick + proteinuria11.236.111.00.000

Funding

  • Private Foundation Support